<i>BCL11B</i> Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia.

"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."

"Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from the Intergovernmental International Cooperation on Scientific and Technological Innovation Project of Chinese Ministry of Science and Technology (No. 2017YFE0131600), National Natural Science Foundation of China (No. 82300176), Guangdong Natural Science Foundation (No. 2023A1515012968), Research Grant of Key Laboratory of Regenerative Medicine, Ministry of Education, Jinan University (No. ZSYXM202204), and the National Science Centre, Poland; Decision no. DEC-2013/09/B/NZ1/01867 (GKP), the National Centre for Research and Development, Poland; Grant No. WPC1/BCL/2019 (GKP)."